e.l.f. Beauty Q1 FY2027 Earnings: 36% Sales Growth Supports Higher Outlook
e.l.f. Beauty (NYSE: ELF) reported fiscal Q1 2027 net sales of $479.4 million, up 36% from $353.7 million, while GAAP diluted EPS rose to $1.12 from $0.58. For the three months ended June 30, 2026, gross margin reached 83%, although IEEPA tariff refunds accounted for most of the expansion, and adjusted EBITDA increased 93% to $168.2 million. The company also raised its fiscal 2027 sales and adjusted profit outlook.
Core earnings results
Sales growth came from both retailer and e-commerce channels across the US and international markets, although the company did not provide a numerical breakdown by channel or geography. Profit increased faster than revenue as gross margin expanded by approximately 1,400 basis points and operating margin rose to about 21.4%.
Higher operating expenses partly offset the gross-profit improvement. GAAP SG&A increased by $84.5 million to $280.3 million, driven primarily by marketing, merchandising and distribution costs, compensation and benefits, and depreciation and amortization.
| Metric | Q1 FY2027 | Q1 FY2026 | YoY change |
|---|---|---|---|
| Net sales | $479.4 million | $353.7 million | +36% |
| Gross profit / margin | $398.8 million / 83% | $244.5 million / 69% | About +63% / +1,400 bps |
| Operating income / margin | $102.4 million / about 21.4% | $48.7 million / about 13.8% | About +110% / +7.6 points |
| GAAP net income | $66.6 million | $33.3 million | About +100% |
| GAAP diluted EPS | $1.12 | $0.58 | About +93% |
| Adjusted diluted EPS | $1.75 | $0.89 | About +97% |
| Adjusted EBITDA / margin | $168.2 million / 35% | $87.1 million / about 24.6% | +93% |
| Operating cash flow | $111.7 million | $27.2 million | About +310% |
Tariff refunds drove most of the margin expansion
Approximately 1,050 basis points of the 1,400-basis-point gross-margin increase came from IEEPA tariff refunds. In other words, the refunds represented about three-quarters of the quarterly expansion. Pricing and lower year-over-year tariff rates accounted for most of the remaining improvement.
Cost of sales consequently declined to $80.5 million from $109.2 million even as revenue increased 36%. This helped adjusted EBITDA grow nearly twice as fast as sales and lifted its margin to 35%. Because the refund benefit explains most of the margin change, the durability of the remaining pricing and tariff-rate benefits will be important when evaluating profitability in subsequent quarters.
Profitability, cash flow and balance sheet
Adjusted SG&A increased by $83.4 million, or approximately 47%, to $260.7 million—faster than revenue growth. The difference between GAAP and adjusted results also widened because adjusted figures excluded stock-based compensation, acquired-intangible amortization and a $16.1 million increase in the fair value of contingent consideration related to the rhode acquisition. The contingent consideration adjustment reflected rhode revenue exceeding the earnout thresholds established in the merger agreement.
Operating cash flow increased to $111.7 million. Higher net income and the absence of the prior-year $46.2 million accounts-receivable cash outflow supported the improvement, although inventory used $26.5 million of cash during the quarter. Inventory reached $246.8 million, up about 45% from $170.4 million a year earlier and about 12% from March 31, 2026.
Cash and cash equivalents stood at $344.2 million, compared with $170.0 million one year earlier. Total debt was also substantially higher at $834.2 million, versus $256.7 million, and quarterly net interest expense increased to $7.8 million from $2.6 million. Financing cash uses included approximately $50.0 million of share repurchases and $7.5 million of debt repayment.
Fiscal 2027 guidance
Management raised its fiscal 2027 outlook across net sales, adjusted EBITDA, adjusted net income and adjusted diluted EPS. CEO Tarang Amin said Q1 represented the company’s 30th consecutive quarter of net sales growth and cited current momentum when explaining the higher outlook; the adjusted tax-rate and diluted-share assumptions were unchanged.
| Metric | Updated FY2027 outlook | Previous outlook | Change |
|---|---|---|---|
| Net sales | $1,938 million-$1,968 million; +18%-20% | $1,835 million-$1,865 million; +12%-14% | Raised |
| Adjusted EBITDA | $401 million-$407 million | $379 million-$385 million | Raised |
| Adjusted net income | $212 million-$215 million | $198 million-$201 million | Raised |
| Adjusted diluted EPS | $3.50-$3.55 | $3.27-$3.32 | Raised |
| Adjusted effective tax rate | 25%-26% | 25%-26% | Unchanged |
| Weighted-average diluted shares | 60.5 million | 60.5 million | Unchanged |
The updated full-year sales-growth range remains below the 36% reported in Q1, making the pace of growth over the remaining fiscal quarters a key measure of execution against the higher targets.
Recent insider transactions
The provided six-month insider summary lists purchases of 625,701 shares across 16 transactions and sales of 314,118 shares across 20 transactions, resulting in net purchases of 311,583 shares. Total insider holdings were listed at 1.45 million shares, with net shares purchased equal to 27.4% under the source’s reported measure.
The latest detailed entries were dominated by sales, along with one derivative-security conversion and one stock gift. The values below are reported transaction amounts rather than share quantities, and no conclusion about insiders’ outlook can be drawn from these transactions alone.
| Date | Insider and role | Transaction | Ownership | Reported value |
|---|---|---|---|---|
| Jul. 1, 2026 | Tarang P. Amin, CEO | Sale at $73.59-$79.74 per share | Direct | $3,924,852 |
| Jul. 1, 2026 | Jennifer Catherine Hartnett, Officer | Sale at $80.00 per share | Direct | $2,028,560 |
| Jul. 1, 2026 | Tarang P. Amin, CEO | Derivative-security conversion at $26.84 per share | Direct | $1,346,402 |
| Jun. 10, 2026 | Tarang P. Amin, CEO | Stock gift at $0.00 per share | Indirect | $0 |
| Jun. 9, 2026 | Scott Kenneth Milsten, General Counsel | Sale at $51.53 per share | Direct | $214,468 |
| Jun. 9, 2026 | Tarang P. Amin, CEO | Sale at $51.53 per share | Direct | $360,710 |
| Jun. 9, 2026 | Mandy J. Fields, CFO | Sale at $51.53 per share | Direct | $222,970 |
| Jun. 9, 2026 | Joshua Allen Franks, Officer | Sale at $51.53 per share | Direct | $180,613 |
| Jun. 9, 2026 | Jennifer Catherine Hartnett, Officer | Sale at $51.53 per share | Direct | $224,259 |
| Jun. 9, 2026 | Kory Marchisotto, Officer | Sale at $51.53 per share | Direct | $224,259 |
Risks investors should monitor
- Gross-margin durability: IEEPA tariff refunds contributed approximately 1,050 basis points to the 1,400-basis-point increase. The release did not quantify how much of this benefit could recur.
- Expense growth: GAAP and adjusted SG&A grew faster than revenue as the company increased marketing, distribution, compensation and related spending. Continued cost growth could reduce operating leverage if sales growth moderates.
- Higher leverage and interest expense: Total debt rose to $834.2 million, while net interest expense nearly tripled to $7.8 million. That increases the importance of sustained cash generation.
- Acquisition-related volatility: The rhode earnout produced a $16.1 million fair-value adjustment because revenue exceeded the specified thresholds. Future adjustments could continue to create differences between GAAP and adjusted earnings.
- Inventory growth: Inventory increased about 45% year over year, faster than the 36% increase in sales, and consumed operating cash during the quarter.
Summary
e.l.f. Beauty’s fiscal Q1 2027 combined 36% sales growth with faster increases in operating income, adjusted EBITDA and operating cash flow. Tariff refunds were the largest contributor to the sharp margin expansion, while rising SG&A, acquisition-related adjustments and higher debt remained counterweights. The next priorities are execution against the raised fiscal 2027 outlook and evidence that underlying margin gains can persist beyond the refund benefit.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles











Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.